Rohto Pharmaceutical Co Ltd
TSE:4527
Rohto Pharmaceutical Co Ltd
Revenue
Rohto Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Revenue
¥263.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Shiseido Co Ltd
TSE:4911
|
Revenue
¥973B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Revenue
¥173.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-1%
|
|
Kao Corp
TSE:4452
|
Revenue
¥1.5T
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
F
|
Fancl Corp
TSE:4921
|
Revenue
¥108.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Revenue
¥173.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
See Also
What is Rohto Pharmaceutical Co Ltd's Revenue?
Revenue
263.6B
JPY
Based on the financial report for Dec 31, 2023, Rohto Pharmaceutical Co Ltd's Revenue amounts to 263.6B JPY.
What is Rohto Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%
Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Rohto Pharmaceutical Co Ltd have been 14% over the past three years , 8% over the past five years , and 7% over the past ten years .